TNFRSF9 and glioblastoma: A study of combining 4-1BB (CD137) activation with anti-CTLA-4 and focal radiotherapy in mice intracranial GBM models revealed that this combination treatment led to an increased TILs density, improving significantly the survival of intracranial GBM model (81).